SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Elamex(ELAMF)
ELAMF 2.150-15.7%Mar 7 3:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Creditman who wrote (16)8/2/1997 11:12:00 AM
From: Ron Bower   of 276
 
C-man,

I have thought all along that Elamex was a good acquisition for a company like Methode, strong on cash, diversified, but not competing with Elamex in product line.

IMO - In a normal market, ELAMF would be considered a strong stock for many reasons, but this market isn't normal. If you aren't showing major growth, the market isn't interested. Stock only moves up or down according to how you perform according to analysts projections. The predictable stocks remain weak. Methode has grown from $5 to $300M over 20 years and will likely reach $1B in a few more, yet it has been valued under others because it is so predictable.

For ELAMF to take off, it must have a great Q and I feel that might be the 4Q. Paul has said repeatedly that it would take patience. I temporarily sold because I had better places for my money over the next 30 days. I don't think we'll see much movement until at least early September.

For what it's worth,
Ron
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News